IFP Advisors, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,528
-77.4%
1,735
-50.0%
0.00%
Q2 2023$20,074
+44.8%
3,470
+100.0%
0.00%
-100.0%
Q1 2023$13,863
+98921.4%
1,7350.0%0.00%
Q4 2022$14
-99.9%
1,7350.0%0.00%
Q3 2022$14,0000.0%1,7350.0%0.00%
Q2 2022$14,000
-50.0%
1,735
-50.0%
0.00%
Q1 2022$28,000
+16.7%
3,470
+100.0%
0.00%
Q4 2021$24,000
-36.8%
1,7350.0%0.00%
-100.0%
Q3 2021$38,000
+90.0%
1,735
+15.7%
0.00%
Q2 2021$20,0001,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders